0.6859

0.87% 0.0059

After Hours: .69 0.0041 +0.60%

Trinity Biotech Plc Adr (TRIB)

Overview News Price History Option Chain Discussions Forecast Stock Split Dividend History

Trinity Biotech Plc Adr stock is traded at $0.6859, with a volume of 41,628. It is up +0.87% in the last 24 hours and up +5.52% over the past month. Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.

Previous Close:

$0.68

Open:

$0.701

24h Volume:

41,628

Relative Volume:

0.05

Market Cap:

$1.55M

Revenue:

$71.39M

Net Income/Loss:

$-28.60M

P/E Ratio:

-0.1834

EPS:

-3.74

Net Cash Flow:

$-12.92M

1W Performance:

-1.87%

1M Performance:

+5.52%

6M Performance:

-23.79%

1Y Performance:

-76.98%

1-Day Range:

$0.6576

$0.71

1-Week Range:

$0.64

$0.71

52-Week Range:

$0.48

$3.39

Trinity Biotech Plc Adr Stock (TRIB) Company Profile

Name

Trinity Biotech Plc Adr

Sector

Healthcare (1161)

Industry

Medical Devices (150)

Phone

Address

Employee

401

Twitter

@TrinityBiotech

Next Earnings Date

2024-08-12

Latest SEC Filings

TRIB's Discussions on Twitter

Compare TRIB with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TRIB Trinity Biotech Plc Adr	0.6859	12.67M	71.39M	-28.60M	-12.92M	-3.74
ABT Abbott Laboratories	126.19	223.66B	43.11B	13.98B	6.66B	7.98
BSX Boston Scientific Corp	104.92	157.95B	18.49B	2.51B	2.72B	1.68
SYK Stryker Corp	392.73	153.02B	23.22B	2.86B	3.58B	7.40
MDT Medtronic Plc	90.24	117.42B	33.54B	4.66B	5.19B	3.62
EW Edwards Lifesciences Corp	79.31	47.61B	5.69B	4.15B	623.10M	6.95

Trinity Biotech Plc Adr Stock (TRIB) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-23-15	Downgrade	Craig Hallum	Buy → Hold
Sep-03-15	Initiated	Raymond James	Outperform
Jul-29-15	Reiterated	ROTH Capital	Buy
Jul-22-08	Reiterated	Roth Capital	Buy
Mar-17-08	Reiterated	Roth Capital	Buy
Dec-10-07	Reiterated	Roth Capital	Buy
Oct-26-07	Reiterated	Roth Capital	Buy

View All

Trinity Biotech Plc Adr Stock (TRIB) Latest News

Jul 24, 2025

Cadence Bank (CADE) Stock: A Year of Market Fluctuations - investchronicle.com

Jul 24, 2025

Jun 24, 2025

Trinity Biotech receives WHO approval for offshore HIV test manufacturing - Investing.com

Jun 24, 2025

Apr 04, 2025

Trinity Biotech Appoints New Interim CFO - Investing.com India

Apr 04, 2025

Mar 31, 2025

Trinity Biotech stock hits 52-week low at $0.62 amid challenges - Investing.com

Mar 31, 2025

Mar 01, 2025

Trinity Biotech (NASDAQ:TRIB) Research Coverage Started at StockNews.com - Armenian Reporter

Mar 01, 2025

Feb 28, 2025

Trinity Biotech stock hits 52-week low at $0.72 amid challenges By Investing.com - Investing.com South Africa

Feb 28, 2025

Trinity Biotech stock hits 52-week low at $0.72 amid challenges - Investing.com

Feb 28, 2025

Trinity Biotech secures amended credit to fuel growth By Investing.com - Investing.com South Africa

Feb 28, 2025

Trinity Biotech secures amended credit to fuel growth - Investing.com India

Feb 28, 2025

Trinity Biotech secures $4m for CGM technology growth - Investing.com

Feb 28, 2025

Feb 27, 2025

Investor Network: Trinity Biotech Plc Sponsored ADR to Host Earnings Call - ACCESS Newswire

Feb 27, 2025

Feb 12, 2025

TRIBTrinity Biotech Announces Quarter 1 Financial Results - br.ADVFN.com

Feb 12, 2025

Feb 11, 2025

Trinity Biotech Announces Quarter 2 Results Revenues of US$36.3m and Operating Profit of US$2.3m - br.ADVFN.com

Feb 11, 2025

Trinity Biotech Announces Quarter 4 Financial Results EPS of 17.1 Cent per Share -- an Increase of 10.3% - br.ADVFN.com

Feb 11, 2025

Trinity Biotech Announces Quarter 3 Results; Revenues Increase to $35.6m; Operating Profit Increases 56% - br.ADVFN.com

Feb 11, 2025

Trinity Biotech stock hits 52-week low at $0.74 amid market challenges - Investing.com

Feb 11, 2025

Trinity Biotech Announces Quarter 3 Financial Results, Acquisition of Blood Bank Screening Business and FDA Approval of HIV-2... - br.ADVFN.com

Feb 11, 2025

Feb 07, 2025